less self-mutilation of the denervated limb, a proxy for restored sensation), microscopic/morphometric (faster axonal regeneration, better-organized neural fascicles, increased density and size of regenerating fibers, and epineural/perineural regeneration), and functional (electromyography and walking recovery via the sciatic functional index)
Retatrutides safety profile is consistent with whats already been observed GLP-1 receptor agonists and combined GLP-1/GIP receptor agonists, meaning the expected side effects are primarily gastrointestinal (GI) in nature: Nausea, vomiting, diarrhea, and constipation
Supports Neuroplasticity Neuroplasticity is the brains ability to rewire itself
The four types of MS each present different challenges for peptide-based interventions
DOI: 10.1371/journal.pone.0020592